These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prevalence of spina bifida at birth--United States, 1983-1990: a comparison of two surveillance systems. Lary JM; Edmonds LD MMWR CDC Surveill Summ; 1996 Apr; 45(2):15-26. PubMed ID: 8602137 [TBL] [Abstract][Full Text] [Related]
8. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011. Williams J; Mai CT; Mulinare J; Isenburg J; Flood TJ; Ethen M; Frohnert B; Kirby RS; MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):1-5. PubMed ID: 25590678 [TBL] [Abstract][Full Text] [Related]
9. Reducing inequities in preventable neural tube defects: the critical and underutilized role of neurosurgical advocacy for folate fortification. Estevez-Ordonez D; Davis MC; Hopson B; ; Arynchyna A; Rocque BG; Fieggen G; Rosseau G; Oakley G; ; Blount JP Neurosurg Focus; 2018 Oct; 45(4):E20. PubMed ID: 30269587 [TBL] [Abstract][Full Text] [Related]
10. Neural tube defects: a review of global prevalence, causes, and primary prevention. Kancherla V Childs Nerv Syst; 2023 Jul; 39(7):1703-1710. PubMed ID: 36882610 [TBL] [Abstract][Full Text] [Related]
11. Etiology, pathogenesis and prevention of neural tube defects. Padmanabhan R Congenit Anom (Kyoto); 2006 Jun; 46(2):55-67. PubMed ID: 16732763 [TBL] [Abstract][Full Text] [Related]
12. Decline in prevalence of neural tube defects in a high-risk region of the United States. Stevenson RE; Allen WP; Pai GS; Best R; Seaver LH; Dean J; Thompson S Pediatrics; 2000 Oct; 106(4):677-83. PubMed ID: 11015508 [TBL] [Abstract][Full Text] [Related]
13. Spina Bifida Prevention: A Narrative Review of Folic Acid Supplements for Childbearing Age Women. Ledet Iii LF; Plaisance CJ; Daniel CP; Wagner MJ; Alvarez I; Burroughs CR; Rieger R; Siddaiah H; Ahmadzadeh S; Shekoohi S; Kaye AD; Varrassi G Cureus; 2024 Jan; 16(1):e53008. PubMed ID: 38406082 [TBL] [Abstract][Full Text] [Related]
14. Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence. Baldacci S; Gorini F; Santoro M; Pierini A; Minichilli F; Bianchi F Epidemiol Prev; 2018; 42(3-4 Suppl 1):1-34. PubMed ID: 30066535 [TBL] [Abstract][Full Text] [Related]
15. Non-Isolated Neural Tube Defects with Comorbid Malformations Are Responsive to Population-Level Folic Acid Supplementation in Northern China. Che X; Liu J; Galea GL; Zhang Y; Greene NDE; Zhang L; Jin L; Wang L; Ren A; Li Z Biology (Basel); 2022 Sep; 11(9):. PubMed ID: 36138850 [TBL] [Abstract][Full Text] [Related]
16. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis--United States, 1985-1994. Cragan JD; Roberts HE; Edmonds LD; Khoury MJ; Kirby RS; Shaw GM; Velie EM; Merz RD; Forrester MB; Williamson RA; Krishnamurti DS; Stevenson RE; Dean JH MMWR CDC Surveill Summ; 1995 Aug; 44(4):1-13. PubMed ID: 7637675 [TBL] [Abstract][Full Text] [Related]
17. Survival of infants with neural tube defects in the presence of folic acid fortification. Bol KA; Collins JS; Kirby RS; Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661 [TBL] [Abstract][Full Text] [Related]
18. Trends in neural tube defects 1980-1989. Bower C; Raymond M; Lumley J; Bury G Med J Aust; 1993 Feb; 158(3):152-4. PubMed ID: 8450777 [TBL] [Abstract][Full Text] [Related]
19. Gene-environment interactions underlying the etiology of neural tube defects. Caiaffa CD; Fonteles CSR; Yunping L; Finnell RH Curr Top Dev Biol; 2023; 152():193-220. PubMed ID: 36707212 [TBL] [Abstract][Full Text] [Related]
20. Inositol, neural tube closure and the prevention of neural tube defects. Greene ND; Leung KY; Copp AJ Birth Defects Res; 2017 Jan; 109(2):68-80. PubMed ID: 27324558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]